Episode Transcript
Transcripts are displayed as originally observed. Some content, including advertisements may have changed.
Use Ctrl + F to search
0:00
Good afternoon. Thank you for joining us. Tarah Schwartz is off this week. I'm
0:01
Kelly Albert, and this is Health
0:04
Matters on CJAD 800. On today's
0:04
show women from racialized
0:09
communities are at a higher risk
0:09
of dying from heart disease.
0:12
Later in the show, we speak with
0:12
the cardiologist from the MUHC
0:15
about her initiative to reduce
0:15
barriers to accessing health
0:18
care. And the Trottier Family
0:18
Foundation has made a
0:21
significant donation to help
0:21
champion a more
0:24
environmentally-friendly
0:24
hospital. But first, this past
0:27
Monday was World Ovarian Cancer
0:27
Day. The MUHC Foundation is
0:31
proud to support many doctors,
0:31
researchers and clinician
0:34
scientists at the MUHC and
0:34
RI-MUHC who are working to find
0:39
a way to diagnose ovarian cancer
0:39
at an earlier stage when it is
0:43
more treatable and find better
0:43
treatments for patients. On
0:47
World Ovarian Cancer Day, a team
0:47
of dedicated volunteers joined
0:50
us for a thank-a-than; a time
0:50
where we could thank our
0:53
community for their support of
0:53
ovarian cancer research and
0:56
patient care. Valerie Aitken is
0:56
one of those dedicated
0:59
volunteers. She has been an
0:59
incredible supporter of the MUHC
1:02
Foundation, and she joins me
1:02
now. Hello, Valerie.
1:05
Hello, Kelly.
1:05
Speak to us this morning.
1:08
Nice to speak with
1:08
you too. We see each other at
1:11
events every once in a while.
1:11
And I just would love to know
1:14
how long have you been
1:14
volunteering with the MUHC
1:17
Foundation?
1:18
My diagnosis
1:18
with ovarian cancer was in 2015
1:23
and I went through the chemo,
1:23
the surgery. Actually in April
1:31
the next year, I said, how do I
1:31
give back? And I asked to speak
1:35
to somebody at the MUHC
1:35
Foundation to inquire as to how
1:43
that could happen.
1:45
That's incredible.
1:45
And it's been ever since. So
1:47
ever since 2016, you've been
1:47
volunteering with us?
1:51
Yes. And I think
1:51
also I was invited to the
1:55
breakfasts, which explained how
1:55
people can not only give money
2:01
in cash, but give shares, and
2:01
all the all the pros and cons of
2:06
that. So it was besides living
2:06
with ovarian cancer, I always
2:11
call it my journey. I don't call
2:11
it a struggle, whatever; it's a
2:15
journey. I learned more, I
2:15
became more financially
2:20
literate, which I thought was
2:20
for me, I always have to look at
2:25
the positive side. If something
2:25
happens, where are we going to
2:29
go. And for me, it's been able
2:29
to support Dr. Gilbert with the
2:33
award. So that is one of the
2:33
things I have been doing.
2:37
I really do admire
2:37
that because I think oftentimes
2:41
when we're faced with a
2:41
diagnosis, it can be very scary.
2:44
It can be a very overwhelming
2:44
time. But I feel that you have
2:49
really made it your mission to
2:49
look at it in a bright way and
2:54
know that you can change the
2:54
world by making these steps to
2:58
make your life more positive.
3:01
Yes, and also,
3:01
of course the people. The first
3:05
award I gave was given to a
3:05
biomedical engineer, and she is
3:09
still my friend. She is
3:09
responsible for part of the
3:13
little brush that's used in the
3:13
clinical trial. And then my
3:18
second award went to help a
3:18
nurse. She'd always already
3:22
registered nurse, but it helped
3:22
her get her master's degree in
3:25
epidemiology. And this is
3:25
somebody else who I've been in
3:30
touch with. And that also is
3:30
wonderful for me to see how
3:36
these people have contributed
3:36
towards Dr. Gilbert's trial.
3:41
Absolutely. So the
3:41
awards that we're speaking about
3:44
is the Valerie Jasset and Gary
3:44
Aitken Cancer Research Award,
3:47
and this goes towards the DOvEE
3:47
Project. We have spoken about
3:51
the DOvEE Project before on the
3:51
show. But for those who don't
3:53
know, it's a project from Dr.
3:53
Lucy Gilbert, which the goal is
3:57
to be like a Pap test for
3:57
ovarian and endometrial cancer.
4:02
The struggle with these cancers
4:02
is they're diagnosed usually at
4:06
a later stage, when it is very
4:06
difficult to treat. And the
4:10
DOvEEgene test, which was
4:10
created right here in Montreal,
4:13
the goal is to have a test so we
4:13
can detect these cancers earlier
4:17
and treat them at an earlier
4:17
stage. And this research awards
4:20
that you created, the amount
4:20
goes directly to Dr. Gilbert who
4:25
helps select a health care
4:25
worker who wants to make a
4:28
difference and is helping to make a difference. Is that correct?
4:31
That's correct.
4:31
Yes, if she has a need, then she
4:38
can use the money. So it's held
4:38
with the MUHC Foundation. I
4:43
think last year's award has not
4:43
been given yet because she's
4:46
looking for the right person to
4:46
give that money to.
4:50
Incredible. We're
4:50
in conversation with Valerie
4:53
Aitken, who is one of the
4:53
dedicated volunteers at MUHC
4:56
Foundation. She's a really
4:56
important part of our community.
4:59
And so you mentioned you are one
4:59
of Dr. Gilbert's patients. You
5:03
mentioned that you've been
5:03
working with the MUHC Foundation
5:05
quite a bit. Why is it important
5:05
for you to support both Dr.
5:09
Gilbert in the DOvEE Project,
5:09
and also just support excellence
5:13
in health care?
5:19
Obviously, I
5:19
spend quite a lot of time back
5:23
and forth between the hospital,
5:23
the clinics and the various
5:25
things. I think for me
5:25
supporting specifically the
5:33
research into ovarian cancer,
5:33
and to look and see how it can
5:39
be found before it becomes stage
5:39
two, stage three, stage four. As
5:48
you mentioned, are so more
5:48
difficult to treat. And with the
5:52
treatment, I have side effects.
5:52
So I am reminded every day, that
5:57
if it hadn't been for Lucy
5:57
Gilbert and her team, then I may
6:03
not be having this conversation
6:03
with you today. But I think this
6:10
is what I want to do. I want to
6:10
have women, particularly younger
6:18
women, this disease can be
6:18
caught nipped in the bud, and
6:24
then they would have a much
6:24
better quality of life. Quality
6:31
of life is what I see. The
6:31
little things that all these
6:36
treatments leave one with.
6:36
Myself, I want to live my life
6:45
as positively and as actively as
6:45
I can, but there are certain
6:51
things that slow you down,
6:51
because of the treatments. So
6:56
that's why my first donations.
6:56
Mind you, I am followed in two
7:05
other particular clinics, and I
7:05
do give money as well towards
7:10
that particular area of
7:10
medicine.
7:17
It's important to
7:17
give back for sure. In
7:19
conversation with Valerie
7:19
Aitken, who is a donor in our
7:22
community, she's a valued
7:22
volunteer of our community.
7:25
We're running short on time,
7:25
Valerie, but I did want to ask
7:28
you, we talk quite a bit about
7:28
giving back. We talk quite a bit
7:33
about philanthropy. What message
7:33
would you have for our listeners
7:37
about the importance of giving
7:37
back; particularly to a cause as
7:41
important as yours, as important
7:41
as the DOvEE Project, and why
7:46
you feel so connected to it?
7:47
Yeah, I think
7:47
people will say to me, I can't
7:50
give very much and perhaps,
7:50
giving $5 a month. Maybe you're
7:58
going to give up that $5 coffee.
7:58
And that's a way of saying, I
8:03
can do this and it's only a
8:03
little amount. But if everybody
8:07
gives a little amount, then I
8:07
see that as a way. It makes me
8:12
feel good when I'm giving
8:12
whether giving of myself or even
8:16
being able to give the award. So
8:16
at that would be my message.
8:20
That's a lovely
8:20
message. And as you mentioned,
8:23
you know, we have a lot of
8:23
information on our website about
8:26
the financial benefits that come
8:26
from it. There's taxable
8:29
benefits that come from this.
8:29
You can become more financially
8:31
literate when you know about the
8:31
different ways to give. And I
8:35
think you're right, any amount,
8:35
no matter the size of the amount
8:39
is an important demonstration
8:39
that you believe in the cause
8:42
and you believe in our
8:42
community. So thank you so much
8:45
for everything that you do for
8:45
us, Valerie. I really appreciate
8:47
your time today. That is Valerie
8:47
Aitken, one of our dedicated
8:52
volunteers and wonderful
8:52
supporters at the MUHC
8:54
Foundation. Next on Health
8:54
Matters, a donation in support
8:58
of making the many surgeries at
8:58
the MUHC more
9:01
environmentally-friendly. Tarah
9:01
Schwartz is off this week. I'm
9:05
Kelly Albert, welcome back to
9:05
Health Matters on CJAD 800. The
9:09
MUHC Foundation is proud to work
9:09
with a number of other
9:12
foundations who support our
9:12
Dream Big campaign and our goal
9:15
to provide excellent patient
9:15
care and push the boundaries
9:18
forward for innovative research
9:18
to find better treatments. The
9:21
Trottier Family Foundation has
9:21
been an important partner and
9:25
has recently donated $280,000 in
9:25
support of a project to reduce
9:29
the environmental impact of
9:29
anesthetic gases. You might know
9:33
that most surgeries are
9:33
performed with anesthetic gases.
9:36
Eric St-Pierre is the Executive
9:36
Director of the Trottier Family
9:39
Foundation and he joins me now
9:39
to talk about this wonderful
9:42
project. Hello, Eric.
9:43
Hi, Kelly. How are you?
9:44
I'm very well, thank you so much for being here. For those who don't know,
9:46
can you tell me a little bit
9:51
about the Trottier Family Foundation?
9:53
Absolutely. So
9:53
the Trottier Family Foundation
9:55
was established by Lorne
9:55
Trottier and Louise Rousselle
9:57
Trottier back in 2006. It was
9:57
created to create a meaningful
10:02
impact to improve the lives of
10:02
Canadians. And so we've had
10:05
about four main programs. So
10:05
we've been focusing a lot on
10:08
science, a lot on education,
10:08
climate change and health
10:12
sectors. For example, we're
10:12
currently at the Climate Summit,
10:17
which has been hosted in the Old
10:17
Port; in partnership with the
10:21
Montreal Climate Partnership.
10:21
And we're currently trying to
10:23
mobilize diverse stakeholders
10:23
around climate change. So I
10:27
would say Trottier Foundation
10:27
has become one of the largest
10:29
Quebec or Canadian funders, and
10:29
one of the biggest funders on
10:33
climate change.
10:35
Absolutely. And
10:35
so, why was it important for you
10:38
to support this project at the
10:38
MUHC- the hospital is already
10:42
eco-friendly, but to make it
10:42
even more eco-friendly?
10:45
Yeah, that's a
10:45
great question. So we started
10:48
analyzing what we could do with
10:48
our health program that might be
10:52
a little bit more proactive, and
10:52
a little bit more innovative,
10:56
and how can we address systemic
10:56
issues. We started realizing
10:59
that often health care is
10:59
treated separately from climate
11:03
change, or climate change is
11:03
treated separately from health.
11:07
But we realized they're actually
11:07
interconnected. They intersect
11:10
and overlap. For example, about
11:10
5% of emissions come from the
11:15
health and hospital sector. So
11:15
this might include buildings
11:19
that are heated on fossil fuels.
11:19
It might include large fleets of
11:22
vehicles, or think of
11:22
ambulances. But it also might
11:26
include things like food waste,
11:26
material supplies, or even
11:30
different gases. Hospitals and
11:30
the health sector is actually a
11:34
very significant emitter of CO2.
11:34
And last year, at the Climate
11:38
Summit, we had that Dr. Steven
11:38
Williams, who's a doctor at the
11:42
CHUM. And the CHUM announced
11:42
that they would go carbon
11:45
neutral by 2040. And this doctor
11:45
had announced a new method for
11:50
reducing emissions from
11:50
anesthetic gases by over 80%. So
11:55
it was sort of an innovative
11:55
first time that Quebec hospital
11:59
was doing something innovative
11:59
and reducing emissions and
12:03
gases. And so we quickly had a
12:03
conversation with the MUHC and
12:07
we thought, wouldn't this be
12:07
great if the MUHC was to become
12:10
the second hospital in Quebec to
12:10
also reduce emissions, and
12:14
anesthetic gases. We had the
12:14
MUHC very willingly contribute.
12:19
We're in conversation with Eric St-Pierre, who's the Executive
12:21
Director of the Trottier Family
12:23
Foundation, the foundation has
12:23
made a donation to the MUHC
12:27
Foundation for $280,000 to
12:27
support a make the MUHC greener
12:33
initiative. And this project,
12:33
particularly, as Eric mentioned,
12:37
pertains to anesthetic gases. So
12:37
I'll give a bit of background on
12:40
anesthetic gases; about 5% of
12:40
the gases used during surgical
12:44
procedures are the ones that are
12:44
absorbed into the body. So 95%
12:49
of the gases are released
12:49
through ventilation systems into
12:52
the environment. So this project
12:52
will help recuperate these gases
12:58
that are released into the
12:58
environment, and then use them
13:01
again, in a way that... I don't
13:01
know the science behind it, but
13:06
I know that they're able to
13:06
recuperate it to make them
13:08
usable again. So it's really
13:08
special, that it's so
13:13
innovative. And it really shows
13:13
forward thinking. Is that
13:16
important to have this
13:16
forward-thinking, innovative,
13:20
outside the box approach to
13:20
finding solutions?
13:23
Yeah, absolutely. I think the challenge is that the health
13:25
sector is so preoccupied with
13:29
significant health issues. We
13:29
just came out of COVID, or we're
13:32
still coming out of COVID. So
13:32
there's very significant issues.
13:37
And it's hard to make
13:37
connections to the climate
13:41
change, whether how we're
13:41
adapting to climate change, what
13:45
the impact of heat waves or
13:45
flooding on Montreal's
13:48
vulnerable populations. But also
13:48
how do we start reducing
13:51
emissions. So we're actually
13:51
starting to see some leadership
13:54
amongst some health institutions
13:54
that are really starting to
13:58
think about those innovative
13:58
ways to directly reduce
14:01
emissions. We're quite inspired
14:01
by this. And we actually think
14:05
that we should be trying to
14:05
scale this across the province.
14:08
We've got now a second hospital
14:08
that's reducing its gases. But
14:11
we'd love to see this spread
14:11
throughout the rest of the
14:13
province, ideally,
14:15
How does that
14:15
happen? Because I think it's
14:18
really difficult. I mean,
14:18
there's so many hospitals in
14:21
Montreal, of varying ages as
14:21
well. We're fortunate that the
14:25
MUHC is a relatively new
14:25
hospital as is the CHUM. And so
14:29
is it conversations? Is it going
14:29
to government officials? Is it a
14:33
little bit of everything?
14:35
Yeah, it's a little bit of everything. So what we're seeing is leadership.
14:37
We're seeing some hospitals,
14:41
being bold and acting as those
14:41
pilot projects and being the
14:45
early adopters, if you will. And
14:45
but what we really need to do
14:48
now is we need to take that
14:48
leadership and we need to start
14:52
putting it to scale. And that
14:52
will actually involve
14:57
conversations with the Quebec
14:57
government and other
15:00
stakeholders as well,
15:00
potentially City of Montreal,
15:04
health officials. We really need
15:04
to start having some
15:07
higher-level conversations with
15:07
the governments and public
15:11
policymakers to really advance
15:11
the discussion of the
15:14
intersection of health and climate.
15:17
We're in conversation with Eric St-Pierre, who is the Executive
15:19
Director of the Trottier Family
15:21
Foundation. What I really admire
15:21
about foundation supporting
15:26
other foundations is it shows
15:26
that we have one goal in mind.
15:32
It's to improve our community
15:32
improve our province, our city,
15:36
our country. And when we support
15:36
each other, I think it just
15:40
shows how important our impact
15:40
can be. And so I love asking the
15:45
guests that come on the show
15:45
with a philanthropic mind; what
15:49
is your message to listeners
15:49
about the importance of the
15:53
impact of philanthropy and
15:53
giving back? Regardless of the
15:57
size of donation, how important
15:57
is giving back?
16:00
Yeah, getting
16:00
back is crucial. For foundations
16:04
like us, philanthropic dollars
16:04
are still very meaningful. The
16:08
grants we're providing are
16:08
helping benefit hospitals in the
16:13
health sector. But it's actually
16:13
very small compared to what
16:16
governments have. And so our
16:16
support from the Trottier
16:20
Foundation, and I would
16:20
encourage other foundations in
16:23
the Montreal area, to really
16:23
look at their funding as being
16:27
catalytic, being bold and
16:27
innovative. So our hope is
16:31
actually that we may mobilize
16:31
other like-minded foundations to
16:35
start thinking about the links
16:35
between climate and health,
16:38
whether that's reducing
16:38
emissions in the health sector,
16:40
or helping vulnerable
16:40
communities adapt to the impacts
16:43
of climate change. I think it's
16:43
a call to action, if you will;
16:48
for funders to start thinking a
16:48
little bit differently.
16:52
For the average
16:52
person to, I think there might
16:55
be a sort of misconception that
16:55
I don't have a lot of money. We
16:59
all experience financial
16:59
insecurity sometimes, and it can
17:02
be difficult to give back. But
17:02
truly, the impact of every
17:06
dollar is really, really
17:06
significant, isn't it?
17:10
Yeah, absolutely. Every dollar works and has an impact. But everybody
17:12
has also a voice, right? So
17:16
everybody could put pressure on
17:16
their local hospital or if they
17:21
have elected officials, they can
17:21
they can contact their local MP
17:26
or local politicians to really
17:26
ask them- what are you doing for
17:29
climate? And what are you doing
17:29
for decarbonizing the health
17:32
sector, for example? There's a
17:32
lot of tools and toolbox for
17:35
everybody.
17:36
Yeah, I love that
17:36
idea. I think we don't
17:38
necessarily always associate
17:38
giving back with time, like
17:41
volunteering or making calls or
17:41
really using your voice to push
17:46
forward to cause it is important
17:46
to you. So I think that's a
17:48
really excellent point.
17:50
We all have to
17:50
try our best and all hands on
17:52
deck, as they say.
17:54
Well, Eric, thank you so much for coming on the show. We really appreciate it.
17:55
And as I mentioned, this
17:59
donation is really going to help
17:59
push forward a more eco-friendly
18:02
hospital and really continue to
18:02
make the MUHC as green as
18:05
possible.
18:06
Thank you, Kelly. I really appreciate being on.
18:08
That is Eric St. Pierre, the executive director of the Trottier Family
18:10
Foundation, the foundation made
18:12
a $280,000 donation to a project
18:12
that will help recuperate
18:17
anesthetic gases and make a less
18:17
environmental impact. Coming up
18:21
on Health Matters, an historic
18:21
discovery that changed how to
18:24
know who is more at risk for
18:24
breast cancer and the local
18:28
researcher who helped make it
18:28
happen. Tarah Schwartz is off
18:31
this week. I'm Kelly Albert, and
18:31
this is Health Matters. The
18:34
BRCA1 and BRCA2 are two genes
18:34
that impact a person's chances
18:39
of developing breast cancer. You
18:39
might have heard of the BRCA
18:42
gene from celebrity news,
18:42
Angelina Jolie decided to have a
18:46
preventative double mastectomy
18:46
after finding she was a carrier
18:49
of the BRCA1 gene. This
18:49
discovery was first reported in
18:53
1994, and one of the scientists
18:53
at the RI-MUHC was part of the
18:58
team that discovered these genes
18:58
and has helped push forward
19:01
research to whom it impacts. Dr.
19:01
Patricia Tonin is a senior
19:04
scientist in the Cancer Research
19:04
Program at the RI-MUHC, she was
19:08
part of the team who discovered
19:08
the gene and joins me now.
19:11
Hello, Dr. Tonin. Hello, thank
19:11
you so much for being here.
19:15
Thank you for having me.
19:17
In very general
19:17
terms, for those who may not
19:19
know what the BRCA1 and BRCA2
19:19
genes are, can you describe them
19:26
to me?
19:26
Yes. So
19:26
these are genes that code for
19:29
proteins that are involved in
19:29
the normal functioning of our
19:35
cells. All of our cells in our
19:35
body have this, we all inherit
19:39
these genes from our parents. We
19:39
have two copies of them, one
19:44
that we inherit from our mothers
19:44
when we inherit from our
19:47
fathers. And what they produce
19:47
are proteins that are important
19:53
to maintain what we call the
19:53
integrity of DNA in the cells.
19:59
Okay, so sometimes
19:59
the cells change or aren't the
20:07
way that they're supposed to be,
20:07
and that impacts your health?
20:10
Yes. So
20:10
what's interesting about these
20:13
two genes is that if you inherit
20:13
a very variant in these genes,
20:21
which we call pathogenic. In
20:21
other words, if you inherited a
20:24
variant that's not a normal
20:24
variant, that would have no
20:28
consequence. But it's something
20:28
that would change the
20:32
functioning of the protein that
20:32
it makes. This results in one of
20:38
two things, either the protein
20:38
that's made is not functioning
20:41
properly, or it's just simply
20:41
not making a protein at all. So
20:45
what happens is that you can
20:45
inherit this variant from either
20:51
parent. And if you do inherit
20:51
it, it significantly increases a
20:57
woman's chance of developing
20:57
breast cancer and ovarian
21:02
cancer. For men, it increases
21:02
could increase your risk for
21:07
developing breast cancer and
21:07
prostate cancer. Depending on
21:12
what gene is involved.
21:14
Wow. And so this
21:14
is a historic discovery, for
21:19
many reasons, but because it
21:19
really helps pinpoint who's more
21:22
at risk of developing these
21:22
cancers.
21:25
Absolutely.
21:25
So they can be used as what we
21:28
call biomarkers. So we knew that
21:28
carriers of either of these
21:33
variants, they develop breast
21:33
cancer on average at a younger
21:37
age. Before the age of 50,
21:37
sometimes as young as in their
21:42
mid-30s. They can develop
21:42
ovarian cancer; perhaps not as
21:47
young but still ovarian cancer
21:47
is quite a deadly disease. The
21:52
risk for developing ovarian
21:52
cancer is lower than the risk
21:55
for breast cancer, but it's
21:55
still a real risk. And because
21:59
the ways in which to treat
21:59
ovarian cancer are not as
22:02
sophisticated as they are for
22:02
breast cancer, it's possible
22:06
that it can be lethal. We now
22:06
know, through years of research
22:11
that men who carry mutations in
22:11
BRCA1 or BRCA2 are at an
22:18
increased risk for breast cancer
22:18
as well. The risk is not the
22:22
same as for women, but it's
22:22
there. And for BRCA2, the most
22:28
important observation is that if
22:28
they carry mutation and they
22:34
develop prostate cancer, it can
22:34
be quite lethal. So the
22:38
management is quite different
22:38
now for men who have prostate
22:43
cancer, and it's known that they
22:43
carry a mutation in one of these
22:47
genes.
22:48
It's really, really fascinating. We're in conversation with Dr. Patricia
22:50
Tonin, a senior scientist in the
22:53
Cancer Research Program at the
22:53
RI-MUHC. So you are one of the
22:57
scientists who was part of the
22:57
team that made this discovery in
23:00
1994. If you could take us back
23:00
to those years. Did you know
23:06
that what you were working on
23:06
was going to be as
23:10
transformative- I guess is the
23:10
word- as it was?
23:13
Yes, yes,
23:13
definitely. Because the way in
23:17
which we found both BRCA1 and
23:17
reported it in the scientific
23:22
literature into the world in
23:22
1994. And then BRCA2, about a
23:26
year later, it was just after
23:26
the holidays, in December of
23:35
1995. We knew then, that it
23:35
would be impactful. What we
23:42
studied were families that had a
23:42
large number of breast cancer
23:46
cases in them, or ovarian
23:46
cancers and breast cancers. We
23:51
knew that the ages of diagnosis
23:51
of breast cancer were young.
23:54
It's the genetic study of these
23:54
families, which led us to
23:58
pinpoint exactly where in the
23:58
human genome these two genes are
24:02
located. So we had genetic
24:02
markers that we knew we're
24:10
tracking in the families, but we
24:10
couldn't find a gene. Until we
24:14
performed some genetic tests,
24:14
which allowed us to pinpoint
24:17
exactly where these genes were.
24:17
And that's the role that I
24:20
played it for BRCA1 and then for
24:20
BRCA2. By pinpointing where to
24:27
look for the genes, it allowed
24:27
our colleagues elsewhere to
24:31
physically clone the genes. Then
24:31
through DNA sequencing, we're
24:35
able to show the link between
24:35
having a variant in one of these
24:40
genes and the gene itself. Then
24:40
itself becomes a marker which
24:47
then can be used to identify all
24:47
the members of the family. Do
24:51
they contain the same variant or
24:51
not? Because everything is
24:55
hereditary, if it is passed from
24:55
one generation to the next. It's
24:59
not what we called de novo, it's
24:59
not something new. It's
25:02
something that's in your family
25:02
and your family history; it
25:04
could be there for hundreds of
25:04
years. And that reveals itself
25:08
when cancer presents itself.
25:08
Perhaps at an unusually younger
25:13
age, or when you have a lot of
25:13
siblings, or close family
25:18
members that have the disease.
25:18
That's how it reveals itself.
25:22
And it becomes a marker for
25:22
family history of disease and
25:26
for the risk.
25:28
Absolutely. And
25:28
that's how your research is
25:30
continuing. You started
25:30
examining the French Canadian
25:32
population
25:33
yes...
25:34
For these markers
25:34
as well. And we're short on
25:37
time. But can you tell us very
25:37
briefly about what your findings
25:40
were in the French Canadian population?
25:42
Yes, we
25:42
published a paper in 1998,
25:44
showing that women who had
25:44
family histories of breast and
25:54
ovarian cancer had very specific
25:54
mutations in either BRCA1 or
26:00
BRCA2 that were tracked in
26:00
individual families. And the
26:03
significance of this at that
26:03
time, was that it provided a way
26:10
to specifically use these as
26:10
genetic markers for finding
26:17
women and men in the population
26:17
who carry these variants, which
26:21
can then be used for genetic
26:21
counseling purposes. So these
26:25
genes, both genes are very, very
26:25
large. They're very complex
26:29
mutations or variants that can
26:29
occur anywhere in the gene. And
26:32
it made it very difficult to
26:32
find the underlying causal
26:37
variant. In specific
26:37
populations, like the French
26:41
Canadians, which can trace their
26:41
ancestors back to common
26:45
founders. They could have
26:45
inherited the same variant in
26:49
their families for generations,
26:49
tracing back to the 1600s. So we
26:54
were able to find those specific
26:54
variants. And at the time the
26:57
discovery was made was
26:57
important, because it allowed us
27:00
to provide a more precise
27:00
genetic counseling advice to
27:05
individuals who may carry these
27:05
mutations. Because sometimes the
27:09
precision was just not there
27:09
with sequencing. Now we have
27:13
sophisticated sequencing methods
27:13
where we can look at the entire
27:17
gene, but back then it was
27:17
costly, it was not necessarily
27:20
available to everyone. And this
27:20
was one way to be able to reach
27:25
a much larger population, as we
27:25
did with the Ashkenazi Jewish
27:32
population, we offered that as
27:32
well. Now we offer genetic
27:35
testing to everyone who is
27:35
eligible for testing.
27:38
It's incredible
27:38
the advances that have been able
27:41
to be made as a part of this
27:41
discovering, because of
27:44
improvements in technology. We
27:44
just have 45 seconds left, Dr.
27:48
Tonin. But you recently were
27:48
part of the team recognized for
27:52
the BRCA1 and 2 gene discovery.
27:52
You received a plaque in London
27:59
at the Cancer Research Institute
27:59
in London. There's a plaque with
28:04
your name as part of the team
28:04
that made this discovery. How
28:06
special is that honor?
28:08
Just to
28:08
clarify that plaque specifically
28:10
for BRCA2 and not for BRCA1
28:10
because those are two separate
28:15
discoveries, same people. So the
28:15
question is, how does it make me
28:19
feel?
28:20
Yes, how is it to
28:20
be recognized that way?
28:23
Fantastic,
28:23
because the purpose behind this
28:28
plaque is what it contains is
28:28
the order of all the authors
28:31
that published the seminal paper
28:31
on the discovery of BRCA2. The
28:37
purpose behind these plaques,
28:37
that are that are on the
28:40
buildings of these Cancer
28:40
Institute's is to recognize team
28:44
science. In other words, is to
28:44
recognize how many people are
28:50
involved to get to the point
28:50
where we can answer a question.
28:56
Rarely are teams recognized.
28:56
Usually, these are individuals.
29:03
It could be the lead author of
29:03
paper or the leader of the team.
29:06
But in reality, when you pull
29:06
the curtain back and you look at
29:10
what's happening in a lab,
29:10
there's a large number of people
29:13
from graduate student trainees,
29:13
undergraduate students, all the
29:17
way up to the team leaders. And
29:17
then this is replicated across
29:22
many, many labs. To be able to
29:22
achieve the successes that we
29:27
were able to achieve as a group
29:27
with the discoveries of these
29:30
two genes is an example of this.
29:30
It required the study of
29:34
geneticists, molecular
29:34
biologists, biologists, breast
29:39
cancer and ovarian cancer and
29:39
prostate cancer specialists from
29:42
around the world to come
29:42
together to be able to do this.
29:46
I could not have been done with
29:46
one particular group or one
29:50
particular team or one
29:50
particular method, it required
29:54
interdisciplinary effort to be
29:54
able to come to this point. And
30:00
the field that I'm in, also
30:00
continues to operate in that way
30:06
and operates quite successfully.
30:06
I mean, there are other genes
30:09
that have been discovered over
30:09
the past 20 years that are also
30:13
known to increased risk for
30:13
breast and ovarian cancer. So
30:17
it's not just those two genes.
30:17
There's now up to 13 different
30:20
genes that have been identified,
30:20
that will allow us to provide
30:28
advice for carriers and what to
30:28
do.
30:30
It's really
30:30
remarkable, and we're so excited
30:33
to have you at the RI-MUHC
30:33
continuing to push the needle
30:36
forward with your research. Dr.
30:36
Tonin, congratulations on this
30:39
recognition. And thank you so
30:39
much for joining us on the show.
30:42
Thank you. Thank you.
30:43
That's Dr. Patricia Tonin, a senior scientist in the Cancer Research
30:44
Program at the RI-MUHC. Coming
30:48
up next on Health Matters, women
30:48
from racialized communities are
30:51
at a higher risk of dying from
30:51
heart disease. Learn how a team
30:54
of doctors at the MUHC want to
30:54
reduce the barriers to accessing
30:58
care. Tarah Schwartz is off this
30:58
week. I'm Kelly Albert and
31:00
you're listening to Health
31:00
Matters. The leading cause of
31:03
death for women in Canada is
31:03
heart disease and cases are
31:06
rising every year. For women in
31:06
racialized communities, the
31:09
rates are even higher. There are
31:09
many reasons why this is
31:12
happening from limited access to
31:12
cardiovascular specialists to
31:15
risks of being overlooked. But
31:15
Dr. Judy Luu hopes to correct
31:19
this with the creation of POWER
31:19
Hub. It's an initiative at the
31:23
MUHC. Cardiologist Dr. Judy Luu
31:23
joins me now to discuss Good
31:25
afternoon, Dr. Luu.
31:27
Hi, good afternoon, Kelly, thank you for having me.
31:30
Thank you so much
31:30
for being here. So do you think
31:32
the average person; and in
31:32
particular, the average woman
31:35
knows their risks of heart
31:35
disease?
31:39
That's an
31:39
excellent question. So we have
31:42
contemporary research to show
31:42
that the average woman actually
31:46
doesn't recognize that heart
31:46
disease is the number one
31:49
killer. So research from the
31:49
United States, which is our
31:51
close neighbor shows that only
31:51
about half a woman recognize
31:55
this very fact. So it definitely
31:55
suggests that there's a lack of
31:58
awareness among a significant
31:58
proportion of women about the
32:01
risk of heart disease. There's
32:01
lots of reasons why this may be.
32:04
I mean, on top of having
32:04
traditional cardiovascular risk
32:07
factors like high blood
32:07
pressure, high cholesterol,
32:10
diabetes, and obesity, a lot of
32:10
women don't know that these risk
32:14
factors impact them much more
32:14
than they do a man. So for
32:17
instance, a woman with diabetes
32:17
is three times more likely to
32:21
die from heart disease when
32:21
compared to a man. So this
32:25
information is currently not
32:25
that fully obvious in the
32:30
public. And so a lot of women do
32:30
underestimate the risk when it
32:33
comes to heart disease.
32:34
Those are really
32:34
big numbers. And, you know,
32:36
we're speaking more specifically
32:36
about women in racialized
32:38
communities. So how much higher
32:38
is that that risk for women in
32:42
racialized communities?
32:46
For Canadian data,
32:46
we don't have an exact number,
32:49
per se. But we do now recognize
32:49
that, racial and ethnic
32:54
disparities do exist when it
32:54
comes to the occurrence of heart
32:58
disease and the outcomes of
32:58
heart disease. And so what do I
33:00
mean by that? For example, from
33:00
the Heart and Stroke Foundation
33:04
of Canada, we know that
33:04
indigenous women do face a
33:09
higher risk of heart disease and
33:09
stroke. And this is due to a
33:11
number of things that are very
33:11
complex. And I want to caveat
33:15
that there's a lot of factors
33:15
like socio-economic factors,
33:20
employment, education, access to
33:20
health services, nutritious
33:23
foods, adequate housing, so all
33:23
of these can impact racialized
33:28
communities and heart disease.
33:28
Indigenous people are just one
33:32
of them. But there's also other
33:32
examples across the multi ethnic
33:36
spectrum. South Asian
33:36
populations in Canada, also have
33:40
higher proportions of heart
33:40
disease. They've shown again, in
33:44
Heart and Stroke, that South
33:44
Asian people oftentimes have up
33:48
to 10 years earlier, chances of
33:48
having heart disease compared to
33:53
their white counterparts. So all
33:53
in all, I say there, again, I
33:58
want to caveat that there's a
33:58
lot of health disparities. And
34:00
the situation is very complex
34:00
and multifaceted. And what I
34:03
mean by multifaceted is there's
34:03
like systemic reasons, societal,
34:07
and health-related reasons. And
34:07
we're only really beginning to
34:10
understand that we're at the
34:10
very tip of this iceberg in
34:13
trying to help resolve this
34:13
current situation.
34:17
Of course, I mean,
34:17
whether it be socio-economic
34:21
factors, as you mentioned, it
34:21
could there could be a variety
34:24
of reasons why this is happening. But it's important to know that it is happening and
34:25
that it's a problem that we can
34:28
try to help with. We're in
34:28
conversation with Dr. Judy Luu,
34:32
a cardiologist at the MUHC, so
34:32
you want to start an initiative
34:36
called POWER. So it's Pathway to
34:36
Cardiovascular Care for Women in
34:41
Ethnic, Racialized and Remote
34:41
Communities. POWER- I really
34:44
liked that acronym. So tell us
34:44
about the POWER Hub and your
34:47
idea behind it.
34:49
Yes. Thank you so much for this opportunity to talk about the POWER Hub. It
34:51
really came as a call to action
34:55
as a national initiative for
34:55
some research funding. When I
35:02
conceptualize the idea; as a
35:02
team of clinicians, researchers,
35:07
women who have lived experience,
35:07
and other community members, we
35:09
definitely recognize that there
35:09
are several deep layers of
35:13
barriers that exist when we come
35:13
to providing equitable care for
35:18
a woman, especially in our
35:18
province in Quebec. And what I
35:22
mean by these barriers are
35:22
things that are including,
35:25
access to specialists, even just
35:25
cultural awareness and
35:29
sensitivities about heart
35:29
disease. There's also a
35:32
physician-patient language
35:32
discordance, especially someone
35:35
doesn't speak English, or if
35:35
they don't speak French in our
35:38
province. And then importantly,
35:38
really systematically we're
35:43
poorly underestimating the risk
35:43
profile of a woman. And so
35:49
that's how the POWER Hub came to
35:49
be. As a new
35:53
clinician-scientist, physician,
35:53
a woman's heart health
35:55
cardiologist at MUHC, I wanted
35:55
to form this network of
36:03
powerhouse team members to
36:03
really bridge the gap between
36:07
the French and the English
36:07
health care system. And to find
36:11
a way how we can redefine how
36:11
cardiovascular care is delivered
36:15
for women in Quebec. So, very
36:15
briefly to the podcast is
36:21
limited. But briefly, the POWER
36:21
Hub is a virtual network that
36:27
comprises of multiple sites
36:27
throughout Quebec. It includes
36:29
the CHUM that includes like
36:29
physician numbers and
36:32
researchers from the CHUM; as
36:32
well as, Laval. And our other
36:36
international collaborators from
36:36
the US including Cedar Sinai in
36:39
Los Angeles. And this POWER Hub
36:39
is designed to co-develop and
36:46
create with our community
36:46
members. So we have the Jamaica
36:54
Association in Montreal, too.
36:54
And the vision really is to
36:57
create a platform where all key
36:57
stakeholders can really work
37:02
together to understand what the
37:02
disparities and health
37:05
disparities are, and to find
37:05
meaningful and effective ways to
37:10
improve those disparities and
37:10
better deliver access to care
37:14
for a woman in Quebec.
37:16
I find it so
37:16
important and inspiring that
37:19
you're working with the
37:19
community stakeholders. Because
37:21
there's so many different groups
37:21
in Montreal that maybe don't
37:25
feel represented in health care
37:25
and for a variety of reasons.
37:29
But I think it's really, really
37:29
wonderful that you're working
37:31
together with these different groups to make sure that everyone feels supported.
37:36
100%, and one of
37:36
our main tripartite leadership
37:40
members is like I said is the
37:40
Jamaica Association but they
37:42
have access to all the other
37:42
black communities in the City of
37:46
Montreal. I think it's very important for us to reach out to. We're in our infancy and
37:48
trying to really garner those
37:54
relationships with these
37:54
cultural and ethnic community
37:56
associations. So eventually, we
37:56
will reach out to, let's say,
37:59
the Iranian community, the Greek
37:59
communities, and so many other
38:03
the Chinese, Vietnamese etc. And
38:03
so it's important for us to
38:07
really build those relationships
38:07
as they help us in the
38:11
fundamental creation of all
38:11
these deliverables of the POWER
38:15
Hub.
38:16
It's really
38:16
inspiring to hear and I know
38:18
that the foundation is
38:18
supporting you through this
38:21
initiative, and we want to get
38:21
you funding to help expand this
38:24
program and get this program off
38:24
the ground. So I'm really
38:26
grateful to have a cardiologist
38:26
like you who's working so
38:29
diligently to help make sure
38:29
that we have full representation
38:32
and equity in health care. Thank
38:32
you so much, Dr. Luu.
38:35
Thank you.
38:36
That is Dr. Judy
38:36
Luu, a cardiologist and one of
38:39
the team members behind the
38:39
POWER Hub and initiative here at
38:43
the MUHC that hopes to bring
38:43
cardiovascular care to women in
38:46
racialized communities. I'm
38:46
Kelly Albert, thank you for
38:49
tuning in. What would you like
38:49
to hear about on the show? Write
38:52
to me at healthmatters at
38:52
MUHCFoundation.com. You can also
38:56
follow the MUHC Foundation on
38:56
social media or sign up for our
39:00
newsletter at our website,
39:00
MUHCFoundation.com. Tarah will
39:03
be back next Sunday. Thank you
39:03
for listening to Health Matters
39:06
and stay healthy.
Podchaser is the ultimate destination for podcast data, search, and discovery. Learn More